Abstract
Introduction

50
Chitosan is a polymer obtained by partial chitin N-deacetylation 1 which has antifungal 51 activity. 2 Chitosan inhibits growth of filamentous fungi and yeast human pathogens.
3,4
52
To develop chitosan as an antifungal treatment, a full understanding of its mode of 53 action is necessary. In Saccharomyces cerevisiae, the response to chitooligosaccharides 54 is mediated by proteins associated with plasma membrane, respiration, ATP production 55 and mitochondrial organization. 5 Five genes (arl1, bck2, erg24, msg5 and rba50) were 56 characterized that provided chitosan resistance when overexpressed or increased 57 sensitivity as a deletion strains. These genes have important roles in signaling pathways,
58
cell membrane integrity and transcription regulation. 5 Other transcriptional studies in S.
To identify transcriptional changes caused by exposure of N. crassa to chitosan a 3- ROS assimilation were also induced at 16h such as NCU05780 (gst-1; Table S2 ). Other significantly expressed (more than 6 fold-change expression, Table S2 ) genes 227 in response to chitosan related with the main functions described previously included also affects cell growth (Fig. 7) . Other transcriptional studies, using S. cerevisiae 296 mutant collections determined genes associated with plasma membrane, respiration,
297
ATP production and mitochondrial organization as main targets of 298 chitooligosaccharides.
5,6
299
In this study, we demonstrated that exposure to chitosan increased the expression of chitosan. 8, 27 In our work, we show that chitosan activates genes related with plasma 308 membrane homeostasis such as the class 3 lipase NCU03639 (Fig. 8) crassa in response to chitosan was finally generated.
559
Figure legends with protein synthesis (NCU04555) and resistance to chemical compounds
